v3.26.3
Provision for Income Taxes
 9 Months Ended
Sep. 30, 2026
Income Tax Disclosure [Abstract]  
Provision for Income Taxes Provision for Income TaxesThe Company recorded income tax expense of $0.7 million and $4.6 million for the three and nine months ended September 30, 2026, respectively, and income tax benefit of $0.7 million and $26.7 million for the same periods in 2025. The tax expense for the nine months ended September 30, 2026 is primarily attributable to an increase in the valuation allowance of $25.4 million and a discrete tax expense related to the shortfall from stock-based compensation, offset by an ordinary tax benefit of $21.5 million. The income tax benefit for the nine months ended September 30, 2025 resulted primarily from a discrete benefit of $20.1 million related to the completion of a research and development tax credit study and $11.1 million of acquisition related tax benefits, offset by ordinary tax expense of approximately $4.6 million.